Elez, E
Hendlisz, A
Delaunoit, T
Sastre, J
Cervantes, A
Varea, R
Chao, G
Wallin, J
Tabernero, J
Article History
Revised: 4 December 2015
Accepted: 14 December 2015
First Online: 14 January 2016
Competing interests
: JS declared receiving honoraria from Lilly, Merck Serono, Roche, Amgen, Sanofi, and Bayer; and research funding from Merck Serono and Bayer. AC declared receiving honoraria from Lilly, Merck Serono, Roche, Amgen, and Bayer; and research funding from Roche, Merck Serono, and Bayer. AH declared receiving honoraria from Ipsen, Bayer, and Roche; and research funding from Bayer, Novartis, Roche, and Sirtex. RV, GC, and JW are employees of Eli Lilly and Company. JT declared consultant/advisory board for Amgen, Boehringer Ingelheim, Celgene, Chugai, Imclone, Lilly, Merck, Merck Serono, Millennium, Sanofi, Symphogen, and Taiho. The remaining authors declare no conflict of interest.